Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: remdesivir
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
WTO Members discuss proposal to suspend certain intellectual property protection during...
Ellen 't Hoen
-
October 14, 2020
Remdesivir developed country price announced
Ellen 't Hoen
-
June 30, 2020
Price, profit and the Covid-19 health technology pool: The example of...
Christopher Garrison
-
May 28, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
Urgent collective action to meet the challenge of this pandemic crisis:...
Christopher Garrison
-
March 30, 2020
Time for new pharmaceutical-innovation models
Ellen 't Hoen
-
February 11, 2020
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok